A recent filing with the Hong Kong Stock Exchange revealed that on April 27, a shareholder of INT MEDICAL transferred shares from Citibank to Merrill Lynch Far East. The transferred shares had a market value of HK$293 million, representing 5.43% of the company's issued share capital. This follows the company's announcement of its annual results for the fiscal year ending December 31, 2025. The company reported revenue of RMB 1.065 billion, a year-on-year increase of 25.06%. Gross profit was RMB 637 million, up 18.44% compared to the previous year. Net profit reached RMB 233 million, reflecting a growth of 22.43%. Earnings per share were RMB 1.26. The board proposed a final dividend of RMB 0.23 per share.
Comments